Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding SOPHiA GENETICS SA changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of SOPH: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders32320
Shares23.3M16.5M−6.73M (−28.9%)
Value$77.2M$51.2M−$26.0M (−33.6%)

New holders (6)

Institutions that held SOPHiA GENETICS SA at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to SOPH in Q2 2025
InstitutionSharesValue% of portfolio
Archon Capital Management LLC321,527$996.7K0.82%
Ensign Peak Advisors, Inc249,944$774.8K0.00%
Rathbone Brothers plc162,483$503.7K0.00%
Goldman Sachs Group Inc18,379$57.0K0.00%
JPMorgan Chase & Co198$6140.00%
Advisor Group Holdings, Inc.55$1820.00%

Sold out (6)

Institutions that held SOPHiA GENETICS SA at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of SOPH in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
UBS Asset Management Americas Inc7,632,871$25.3M
Alta Wealth Advisors LLC1,409,160$4.68M
Moloney Securities Asset Management, LLC23,500$78.0K
FNY Investment Advisers, LLC6,833$22.0K
Coldstream Capital Management Inc224$744
Steward Partners Investment Advisory, LLC15$50